THE SCOTTS MIRACLE-GRO COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 66.74 USD | -1.80% |
|
-3.89% | +4.69% |
| Apr. 08 | North American Morning Briefing : Inflation Data, -2- | DJ |
| Apr. 05 | UBS Raises Scotts Miracle-Gro's Price Target to $79 From $63, Maintains Neutral Rating | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- One of the major weak points of the company is its financial situation.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Agricultural Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +4.69% | 3.85B | B- | ||
| +14.36% | 37.71B | C | ||
| -.--% | 10.93B | - | B+ | |
| -8.30% | 7.11B | A | ||
| +5.61% | 6.74B | B- | ||
| -2.75% | 6.01B | B+ | ||
| -5.56% | 5.6B | B | ||
| +37.95% | 5.28B | B- | ||
| -20.36% | 5.05B | - | C- | |
| +21.61% | 4.54B | - | - |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- SMG Stock
- Ratings The Scotts Miracle-Gro Company
